C U R R I C U L U M V I T A E
GEMMA MARCUCCI
Bone metabolic diseases unit, Department of Biomedical, Experimental and Clinical Sciences,
University of Florence, AOU Careggi, Florence, Italy.
Largo Palagi 1, 50139, Florence (Italy)
ACADEMIC AND EDUCATION
TITLES
Date 2000
Italian diploma (classical High School "Galileo"), Florence, Italy.
Date 2006
Degree in Medicine and Surgery, University of Florence, vote 110/110 cum laude. Thesis Title:
"Fosfatonin: The New Regulators Of Phosphate" Supervisor Prof. ML Brandi, co-supervisor Dr.
Date 2012
Postgraduate in Endocrinology and Metabolic Diseases, Thesis Title: "Hypoparathyroidism:
diagnosis, clinical andcurrent and future therapies", Supervisor: Prof. G. Forti, co-supervisor:
Florence, Italy.
Date 2017
PhD of Clinical Sciences (Pathology and clinic of the musculoskeletal system and calcified tissues), Cycle XXVIII, University of Florence, Italy. Thesis Title: "Refractory hypoparathyroidism and treatment with recombinant human PTH [rhPTH (1-34): Teriparatide]", Supervisor: Prof. ML Brandi Florence, Italy.
2016 September – 2022 March
Research Fellow MD, PhD Department of Experimental and Clinical Biomedical Sciences
University of Florence, Italy, Bone Metabolic Diseases Unit University Hospital of Florence.
2022 April – 2025 March
Assistant Professor MD, PhD Department of Experimental and Clinical Biomedical Sciences
2025 April – now
Associate Professor of Endocrinology and Metabolic Diseases. Department of Experimental and Clinical Biomedical Sciences University of Florence, Italy, Bone Metabolic Diseases Unit. University Hospital of Florence.
NATIVE LANGUAGE: Italian
FOREIGN LANGUAGES: English
CLINICAL RESEARCH EXPERIENCE
Her research activities focus primarily on both rare and common disorders of mineral and bone metabolism, as well as parathyroid disorders, encompassing clinical, epidemiological, genetic, pharmacogenetic, radiological, cellular, and molecular research. Her main research interests include secondary osteoporosis and rare disorders of mineral and bone metabolism, particularly X-linked hypophosphatemia (XLH), hypophosphatasia, and osteogenesis imperfecta. Since 2013, she has been involved in several clinical trials on hypophosphatasia, chronic hypoparathyroidism, and X-linked hypophosphatemia.
Publications of scientific papers in international and national journals:
2008
1. Massart F, Marcucci G, Brandi ML. Pharmacogenetics of bone treatments: the VDR and ERalpha gene story. 2008. PMID:18518851. [Rivista, volume, fascicolo e pagine da verificare].
2. Marcucci G, Masi L, Brandi ML. Phosphatonins: new hormones that control phosphorus homeostasis. Expert Rev Endocrinol Metab. 2008;3(4):513-526.
3. Cepollaro C, Monaco R, Marcucci G. Cosegregation of cardiovascular diseases and osteoporosis: instrumental diagnosis. Clin Cases Miner Bone Metab. 2008;5(1):40-44.
2009
4. Cepollaro C, Monaco R, Cioppi F, Masi L, Falchetti A, Marcucci G, Caracchini G, D'Elia G, Tanini A, Brandi ML. QUS, BMD and QCT in women with established osteoporosis treated with teriparatide. J Clin Densitom. 2009;12(1):118-119.
5. Masi L, Gozzini A, Franchi A, Campanacci D, Amedei A, Falchetti A, Franceschelli F, Marcucci G, Tanini A, Capanna R, Brandi ML. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis. J Bone Joint Surg Am. 2009;91(5):1190-1198.
6. Cavalli L, Cavalli T, Marcucci G, Falchetti A, Masi L, Brandi ML. Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women. Clin Cases Miner Bone Metab. 2009;6(2):169-173.
7. Marcucci G, Brandi ML. Vertebroplasty and balloon kyphoplasty in osteoporosis: friends or foes? Clin Cases Miner Bone Metab. 2009;6(3):203-209.
2010
8. Marcucci G, Brandi ML. Kyphoplasty and vertebroplasty in the management of osteoporosis with subsequent vertebral compression fractures. Clin Cases Miner Bone Metab. 2010;7(1):51-60.
2011
9. Catarzi S, Romagnoli C, Marcucci G, Favilli F, Iantomasi T, Vincenzini MT. Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. Biochim Biophys Acta. 2011 Jan 20.
10. Piscitelli P, Marcucci G, Parri S, Cavalli L, Colli E, Pazzagli L, Batacchi P, Brocca T, Giovannini V, Brandi ML. Compliance to antifracture treatments in Tuscany: a regional survey based on institutional pharmaceutical dataset. Clin Cases Miner Bone Metab. 2011;8(3):62-65.
11. Falcini F, Masi L, Cavalli L, Gozzini A, Franceschelli F, Falchetti A, Amedei A, Marcucci G, Fossi C, Tanini AL, Brandi ML. Mutations in GALNT3 gene: two adolescents with tumoral calcinosis-hyperphosphatemia. Clin Exp Rheumatol. 2011;29:379-380. ISSN: 0392-856X.
2012
12. Falchetti A, Cavalli L, Cavalli T, Giusti F, Marcucci G, Marini F, Brandi ML. Molecular diagnosis of parathyroid carcinoma: a reality in the near future. Expert Opin Med Diagn. 2012;6(1):27-37.
13. Piscitelli P, Iolascon G, Argentiero A, Chitano G, Neglia C, Marcucci G, Pulimeno M, Benvenuto M, Mundi S, Marzo V, Donati D, Baggiani A, Migliore A, Granata M, Gimigliano F, Di Blasio R, Gimigliano A, Renzulli L, Brandi ML, Distante A, Gimigliano R. Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. Clin Interv Aging. 2012;7:575-583.
2013
14. Romagnoli C, Marcucci G, Favilli F, Zonefrati R, Mavilia C, Galli G, Tanini A, Iantomasi T, Brandi ML, Vincenzini MT. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. FEBS J. 2013;280(3):867-879.
15. Longato L, Cavalli L, Marcucci G, Metozzi A, Giusti F, Brandi ML, Piscitelli P. Osteonecrosis of the jaw in a patient with rheumatoid arthritis treated with an oral aminobisphosphonate: a clinical case report. Clin Cases Miner Bone Metab. 2013;10(2):139-141.
16. Marcucci G, Masi L, Carossino AM, Franchi A, Capanna R, Sinigaglia L, Brandi ML. Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature. Calcif Tissue Int. 2013 Jul 9.
17. Marcucci G, Masi L, Cavalli L, Fossi C, Franceschelli F, Brandi ML. Is calcium signaling relevant for long bone growth? Bone. 2013;57(1):105-110.
2014
18. Masi L, Ottanelli S, Berni R, Cacudi E, Giusti F, Marcucci G, Cavalli L, Fossi C, Marini F, Ciuffi S, Tanini A, Brandi ML. CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapy. Clin Cases Miner Bone Metab. 2014:36-43. ISSN: 1724-8914.
19. Marcucci G, Zimran A, Bembi B, Kanis J, Reginster JY, Rizzoli R, Cooper C, Brandi ML. Gaucher disease and bone manifestations. Calcif Tissue Int. 2014;95(6):477-494.
20. Marcucci G, Cianferotti L, Beck-Peccoz P, Capezzone M, Cetani F, Colao A, Davi MV, Degli Uberti E, Del Prato S, Elisei R, Faggiano A, Ferone D, Foresta C, Fugazzola L, Ghigo E, Giacchetti G, Giorgino F, Lenzi A, Malandrino P, Mannelli M, Marcocci C, Masi L, Pacini F, Opocher G, Radicioni A, Tonacchera M, Vigneri R, Zatelli MC, Brandi ML. Rare diseases in clinical endocrinology: a taxonomic classification system. J Endocrinol Invest. 2014 Nov 7.
2015
21. Fontani F, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling. Calcif Tissue Int. 2015;96(4):335-346. doi:10.1007/s00223-015-9961-0.
22. Masi L, Beltrami G, Ottanelli S, Franceschelli F, Gozzini A, Zonefrati R, Galli G, Ciuffi S, Mavilia C, Giusti F, Marcucci G, Cioppi F, Colli E, Fossi C, Franchi A, Casentini C, Capanna R, Brandi ML. Human preosteoblastic cell culture from a patient with severe tumoral calcinosis-hyperphosphatemia due to a new GALNT3 gene mutation: study of in vitro mineralization. Calcif Tissue Int. 2015;96(5):438-452. doi:10.1007/s00223-015-9974-8.
23. Parri S, Cianferotti L, Marcucci G, Gronchi G, Rizzuti C, Colli E, Manetti B, Naldoni W, Brandi ML. The T.A.R.Ge.T. project: a regional program to reduce hip fracture in elderly patients. Main results of retrospective phase. Clin Cases Miner Bone Metab. 2015;12(1):34-42. doi:10.11138/ccmbm/2015.12.1.034.
24. Marcucci G, Brandi ML. Rare causes of osteoporosis. Clin Cases Miner Bone Metab. 2015;12(2):151-156. doi:10.11138/ccmbm/2015.12.2.151.
2016
25. Marcucci G, Della Pepa G, Brandi ML. Natpara for the treatment of hypoparathyroidism. Expert Opin Biol Ther. 2016;16(11):1417-1424.
2017
26. Marcucci G, Della Pepa G, Brandi ML. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism. Expert Opin Drug Saf. 2017;16(5):617-625. doi:10.1080/14740338.2017.1311322.
27. Domazetovic V, Fontani F, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Estrogen inhibits starvation-induced apoptosis in osteocytes by a redox-independent process involving association of JNK and glutathione S-transferase P1-1. FEBS Open Bio. 2017;7(5):705-718. doi:10.1002/2211-5463.12216.
28. Domazetovic V, Fontani F, Tanini D, D'Esopo V, Viglianisi C, Marcucci G, Panzella L, Napolitano A, Brandi ML, Capperucci A, Menichetti S, Vincenzini MT, Iantomasi T. Protective role of benzoselenophene derivatives of resveratrol on induced oxidative stress in intestinal myofibroblasts and osteocytes. Chem Biol Interact. 2017 Jul 20. pii:S0009-2797(17)30202-8.
29. Tarantino U, Iolascon G, Cianferotti L, Masi L, Marcucci G, Giusti F, Marini F, Parri S, Feola M, Rao C, Piccirilli E, Zanetti EB, Cittadini N, Alvaro R, Moretti A, Calafiore D, Toro G, Gimigliano F, Resmini G, Brandi ML. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. J Orthop Traumatol. 2017;18(Suppl 1):3-36. doi:10.1007/s10195-017-0474-7.
30. Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Oxidative stress in bone remodeling: role of antioxidants. Clin Cases Miner Bone Metab. 2017;14(2):209-216.
31. Marcucci G, Della Pepa G, Brandi ML. Hypoparathyroidism and treatment with recombinant human PTH. Expert Opin Orphan Drugs. 2017;5(6).
2018
32. Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S, Betterle C, Bondanelli M, Boscaro M, Camozzi V, Centaro GM, Cetani F, Chiodini I, Ciampolillo A, Colao A, Corbetta S, De Feo ML, Degli Uberti E, Faggiano A, Fornari R, Gaspari AL, Giorgino F, Giuliani V, Iacobone M, Innaro N, Lamacchia O, Lenzi A, Mantovani G, Marcocci C, Masi L, Migliaccio S, Palmieri S, Pasquali R, Perigli G, Piccini V, Romagnoli E, Ruggeri RM, Rulli F, Sama MT, Tomaino G, Trimarchi F, Zatelli MC, Brandi ML. HypoparaNet: a database of chronic hypoparathyroidism based on expert medical-surgical centers in Italy. Calcif Tissue Int. 2018;103(2):151-163. doi:10.1007/s00223-018-0411-7.
33. Cianferotti L, Parri S, Gronchi G, Marcucci G, Cipriani C, Pepe J, Raglianti M, Minisola S, Brandi ML. Prevalence of chronic hypoparathyroidism in a Mediterranean region as estimated by the analysis of anonymous healthcare database. Calcif Tissue Int. 2018;103(2):144-150. doi:10.1007/s00223-018-0405-5.
34. Marcucci G, Masi L, Ferrari S, Haffner D, Javaid MK, Kamenicky P, Reginster JY, Rizzoli R, Brandi ML. Phosphate wasting disorders in adults. Osteoporos Int. 2018 Jul 16. doi:10.1007/s00198-018-4618-2.
35. Vannucci L, Fossi C, Quattrini S, Guasti L, Pampaloni B, Gronchi G, Giusti F, Romagnoli C, Cianferotti L, Marcucci G, Brandi ML. Calcium intake in bone health: a focus on calcium-rich mineral waters. Nutrients. 2018;10(12):1930. doi:10.3390/nu10121930.
36. Cianferotti L, Marcucci G, Brandi ML. Causes and pathophysiology of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):909-925. doi:10.1016/j.beem.2018.07.001.
37. Marcucci G, Cianferotti L, Brandi ML. Clinical presentation and management of hypoparathyroidism. Best Pract Res Clin Endocrinol Metab. 2018;32(6):927-939. doi:10.1016/j.beem.2018.09.007.
38. Marini F, Masi L, Marcucci G, Cianferotti L, Brandi ML. Genetics of osteoporosis. In: Lenzi A, Migliaccio S, editors. Multidisciplinary Approach to Osteoporosis: From Assessment to Treatment. Cham: Springer; 2018. doi:10.1007/978-3-319-75110-8.
2019
39. Marcucci G, Brandi ML. A new era for chronic management of hypoparathyroidism: parathyroid hormone peptides. Front Horm Res. 2019;51:165-171. doi:10.1159/000491047.
40. Marcucci G, Brandi ML. Conventional treatment of hypoparathyroidism. Front Horm Res. 2019;51:160-164. doi:10.1159/000491046.
41. Domazetovic V, Marcucci G, Pierucci F, Bruno G, Di Cesare Mannelli L, Ghelardini C, Brandi ML, Iantomasi T, Meacci E, Vincenzini MT. Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1. FEBS Open Bio. 2019;9(6):1082-1096. doi:10.1002/2211-5463.12634.
42. Marcucci G, Beltrami G, Tamburini A, Body JJ, Confavreux CB, Hadji P, Holzer G, Kendler D, Napoli N, Pierroz DD, Rizzoli R, Brandi ML. Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors. Ann Oncol. 2019;30(6):908-920. doi:10.1093/annonc/mdz120.
2020
43. Domazetovic V, Marcucci G, Falsetti I, Bilia AR, Vincenzini MT, Brandi ML, Iantomasi T. Blueberry juice antioxidants protect osteogenic activity against oxidative stress and improve long-term activation of the mineralization process in human osteoblast-like SaOS-2 cells: involvement of SIRT1. Antioxidants (Basel). 2020;9(2):125. doi:10.3390/antiox9020125.
2021
44. Marcucci G, Brandi ML. Congenital conditions of hypophosphatemia expressed in adults. Calcif Tissue Int. 2021;108(1):91-103. doi:10.1007/s00223-020-00695-2.
45. Marcucci G, Masi L, Cianferotti L, Giusti F, Fossi C, Parri S, Gronchi G, Brandi ML. Chronic hypoparathyroidism and treatment with teriparatide. Endocrine. 2021;72:249-259. doi:10.1007/s12020-020-02577-x.
46. Donati S, Palmini G, Romagnoli C, Aurilia C, Miglietta F, Falsetti I, Marini F, Zonefrati R, Galli G, Marcucci G, Iantomasi T, Brandi ML. In vitro non-genomic effects of calcifediol on human preosteoblastic cells. Nutrients. 2021;13(12):4227. doi:10.3390/nu13124227.
47. Marcucci G, Altieri P, Benvenga S, Bondanelli M, Camozzi V, Cetani F, Cianferotti L, Duradoni M, Fossi C, Degli Uberti E, Fama F, Mantovani G, Marcocci C, Masi L, Pagotto U, Palermo A, Parri S, Ruggeri RM, Zatelli MC, Brandi ML; Hypoparathyroidism Working Group affiliated to the Italian Society of Endocrinology. Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study. Orphanet J Rare Dis. 2021;16(1):421. doi:10.1186/s13023-021-02053-3.
48. Masi L, Marini F, Franceschelli F, Leoncini G, Cianferotti L, Cioppi F, Giusti F, Marcucci G, Gronchi G, Brandi ML. Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia? Osteoporos Int. 2021;32(12):2461-2472. doi:10.1007/s00198-021-05893-8.
2022
49. Marcucci G, Beccuti G, Carosi G, Cetani F, Cianferotti L, Colao AM, Di Somma C, Duradoni M, Elefante A, Ghizzoni L, Giusti M, Lania AG, Lavezzi E, Madeo B, Mantovani G, Marcocci C, Masi L, Parri S, Pigliaru F, Santonati A, Spada A, Vera L, Brandi ML. Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH(1-84) treatment. J Endocrinol Invest. 2022;45(9):1653-1662. doi:10.1007/s40618-022-01800-y.
50. Marini F, Masi L, Giusti F, Cianferotti L, Cioppi F, Marcucci G, Ciuffi S, Biver E, Toro G, Iolascon G, Iantomasi T, Brandi ML. ALPL genotypes in patients with atypical femur fractures or other biochemical and clinical signs of hypophosphatasia. J Clin Endocrinol Metab. 2022;107(5):e2087-e2094. doi:10.1210/clinem/dgab914. PMID:34935951.
51. Domazetovic V, Falsetti I, Ciuffi S, Iantomasi T, Marcucci G, Vincenzini MT, Brandi ML. Effect of oxidative stress-induced apoptosis on active FGF23 levels in MLO-Y4 cells: the protective role of 17-beta-estradiol. Int J Mol Sci. 2022;23(4):2103. doi:10.3390/ijms23042103.
52. Collins MT, Marcucci G, Anders HJ, Beltrami G, Cauley JA, Ebeling PR, Kumar R, Linglart A, Sangiorgi L, Towler DA, Weston R, Whyte MP, Brandi ML, Clarke B, Thakker RV. Skeletal and extraskeletal disorders of biomineralization. Nat Rev Endocrinol. 2022;18(8):473-489. doi:10.1038/s41574-022-00682-7.
2023
53. Marcucci G, Domazetovic V, Nediani C, Ruzzolini J, Favre C, Brandi ML. Oxidative stress and natural antioxidants in osteoporosis: novel preventive and therapeutic approaches. Antioxidants (Basel). 2023;12(2):373. doi:10.3390/antiox12020373.
54. Collins MT, Marcucci G, Anders HJ, Beltrami G, Cauley JA, Ebeling PR, Kumar R, Linglart A, Sangiorgi L, Towler DA, Weston R, Whyte MP, Brandi ML, Clarke B, Thakker RV. Author correction: Skeletal and extraskeletal disorders of biomineralization. Nat Rev Endocrinol. 2023;19(1):62. doi:10.1038/s41574-022-00768-2.
2024
55. Marini F, Marcucci G, Giusti F, Arvat E, Benvenga S, Bondanelli M, Castellino L, Camozzi V, Corbetta S, Davi MV, Fama F, Ferone D, Iacobone M, Loli P, Mantovani G, Pagotto U, Persani L, Perigli G, Piovesan A, Repaci A, Ruggeri RM, Eller-Vainicher C, Vera L, Zatelli MC, Zavatta G, Brandi ML. Parathyroid carcinoma and atypical parathyroid tumor: analysis of an Italian database. Eur J Endocrinol. 2024;191(4):416-425. doi:10.1093/ejendo/lvae121.
56. Marcucci G. Antiresorptive drugs' role in management of postmenopausal osteoporosis. In: Endocrinology. Switzerland: Springer; 2024. Part F3708. [Book chapter].
2025
57. Marcucci G, Brandi ML. The diagnosis and therapy of osteoporosis in Gaucher disease. Calcif Tissue Int. 2025;116(1):31. doi:10.1007/s00223-024-01340-y.
58. Marini F, Giusti F, Weiss B, Ovize M, Benvenga S, Cetani F, Colao A, Corbetta S, Bondanelli M, Iacobone M, Lenzi A, Mantovani G, Ruggeri RM, Di Filippo L, Giustina A, Ali DS, Khan AA, Marcucci G, Brandi ML; HypoparaNet team. Bone status in patients with chronic hypoparathyroidism: results from the Italian HypoparaNET database. Aging Clin Exp Res. 2025;37(1):230. doi:10.1007/s40520-025-03139-9. PMID:40702385.
59. Arcidiacono GP, Camozzi V, Tripepi G, Eller-Vainicher C, Vezzoli G, Brandi ML, Marcucci G, Girasole G, Aversa A, Vitale C, Cerbone G, D'Alessandro MM, Zaninotto M, Fusaro M, Torres MO, Cannito M, Cecchinato A, Diogo M, Peleg Falb M, Guidolin F, Zampogna M, Plebani M, Campello E, Simioni P, Sella S, Giannini S. Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort. J Endocrinol Invest. 2025 May 5. doi:10.1007/s40618-025-02596-3.
2026
60. Marcucci G, Biver E, Body JJ, Campusano C, Cannata-Andia J, Confavreux C, de Villiers TJ, Ebeling PR, Hadji P, Kendler D, El Maghraoui A, Napoli N, Veronesi P, Rizzoli R, Brandi ML. Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next? Osteoporos Int. 2026;37(2):341-360. doi:10.1007/s00198-025-07798-2.
61. Carrara S, Baroncelli GI, Arcidiacono GP, Barale M, Brandi ML, Camozzi V, Castellano E, Cetani F, Comberiati P, Della Valentina S, Eller-Vainicher C, Foligno NE, Giannini S, Gianotti L, Grassi G, Lagana M, Lai S, Marcucci G, Masi L, Paglia F, Palermo A, Perrotta AM, Pigliaru F, Procopio M, Rochira V, Rotondi S, Ruggeri RM, Torres MO, Vai S, Vezzoli G, Zampogna M, Corbetta S. Clinical features of Italian adult individuals with X-linked hypophosphatemia: a multicenter retrospective study. Endocr Connect. 2026 Apr 1:EC-25-0756. doi:10.1530/EC-25-0756.
62. Gamage TH, Coutinho S, Leardini A, Alves I, Grossmann N, Sakkers R, Marcucci G, Masi L, Brandi ML, Zillikens MC, Trisolino G, Wekre LL, Horn J. Clinical decision-making in rare bone diseases: a survey among members of the European Paediatric Orthopaedic Society (EPOS) and the European Reference Network on Rare Bone Diseases (ERN BOND). J Child Orthop. 2026;20(4):428-439. doi:10.1177/18632521261439074. eCollection 2026 Aug.
Legenda
Professional Experience
Date
from 2008 until now
54 Publications of scientific papers on basic and clinical research regarding bone and mineral metabolism in international and national journals (see attachment, Pag 2-5)
2013-2014
from 2013 until now
Scientific investigator in clinical protocols regarding osteoporosis medications and rare diseases.
I certify to practice medicine according to GCP (Good Clinical Practice).
2013-2017
PhD of Clinical Sciences (Pathology and clinic of the musculoskeletal system and calcified tissues), Cycle XXVIII, University of Florence, Italy.
September 2016 - March 2022
Research fellow of Endocrinology, University of Florence
March 2022 – until now
Assistant Professor of Endocrinology, University of Florence
Academic and Education Titles
2000
2006
Degree in Medicine and Surgery, University of Florence, vote 110/110 cum laude. Thesis Title: "Fosfatonin: The New Regulators Of Phosphate" Supervisor Prof. ML Brandi, co-supervisor Dr. L. Masi.
Postgraduate in Endocrinology and Metabolic Diseases, Thesis Title: "Hypoparathyroidism: diagnosis, clinical andcurrent and future therapies", Supervisor: Prof. G. Forti, co-supervisor: Prof. ML Brandi. Faculty of Medicine, Department of Clinical Pathophysiology, University of Florence, Italy.
PhD of Clinical Sciences (Pathology and clinic of the musculoskeletal system and calcified tissues), Cycle XXVIII, University of Florence, Italy. Thesis Title: "Refractory hypoparathyroidism and treatment with recombinant human PTH [rhPTH (1-34): Teriparatide]", Supervisor: Prof. ML Brandi. Faculty of Medicine, Department of Medicine and Translational Surgery, University of Florence, Italy.
Research Fellow MD, PhD Department of Experimental and Clinical Biomedical Sciences University of Florence, Italy, Bone Metabolic Diseases Unit University Hospital of Florence.
2022 April – until now
Assistant Professor MD, PhD Department of Experimental and Clinical Biomedical Sciences University of Florence, Italy, Bone Metabolic Diseases Unit University Hospital of Florence.
Native Language
Italian
Foreign Languages
Clinical Research Experience
English
Her major research interests include: genetic, clinical, radiological, pharmacogenetic, cellular and molecular investigation of metabolic bone disorders, rare congenital metabolic bone diseases, parathyroid disorders, and of genetic, clinical, and molecular features of hereditary endocrinological tumors. Her major research activities are related to basic and clinical/epidemiological studies on metabolic bone disorders; clinics, genetics and pharmacogenetics of osteoporosis and other bone disorders; genetics of paget’s disease of bone; bone, endocrine and stem cell biology; basic and clinical studies on parathyroid diseases and pathogenesis of primary hyperparathyroidism.
Publications of scientific papers in international and national journals
1) Massart F., Marcucci G., Brandi ML.
Pharmacogenetics of bone treatments: the VDR and ER alpha gene story.
Pharmacogenomics. 2008 Jun;9(6):733-46. Review.
2) Marcucci G., Masi L., Brandi ML.
Phosphatonins: new hormones that control phosphorus homeostasis.
Expert Review of Endocrinology and Metabolism, Volume 3, Number 4, July 2008 , pp. 513-526(14).
3) Cepollaro C., Monaco R., Marcucci G.
Cosegregation of cardiovascular diseases and osteoporosis: instrumental diagnosis
Clin Cases Miner Bone Metab. 2008 Jan-Apr; 5(1): 40–44.
4) Cepollaro C., Monaco R., Cioppi F., Masi L., Falchetti A., Marcucci G., Caracchini G., D'Elia G., Tanini A., Brandi ML.
QUS, BMD and QCT in Women with Established Osteoporosis Treated with Teriparatide.
Journal of Clinical Densitometry, Volume 12, Issue 1, Pages 118-119, January 2009.
5) Masi L., Gozzini A., Franchi A., Campanacci D., Amedei A., Falchetti A., Franceschelli F., Marcucci G., Tanini A., Capanna R., Brandi ML.
A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
J Bone Joint Surg Am. 2009 May;91(5):1190-8.
6) Cavalli L., Cavalli T., Marcucci G., Falchetti A., Masi L., and Brandi ML.
Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women.
Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173. CIC Edizioni Internazionali.
7) Marcucci G. and Brandi ML.
Vertebroplasty and balloon kyphoplasty in osteoporosis: friends or foes?
Clin Cases Miner Bone Metab. 2009 Sep–Dec; 6(3): 203–209 CIC Edizioni Internazionali.
8) Marcucci G. and Brandi ML.
Kyphoplasty and vertebroplasty in the management of osteoporosis with subsequent vertebral compression fractures.
Clin Cases Miner Bone Metab. 2010 Jan–Apr; 7(1): 51–60. CIC Edizioni Internazionali.
9) Catarzi S., Romagnoli C., Marcucci G., Favilli F., Iantomasi T., Vincenzini MT.
Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: Involvement of NADPH oxidase and platelet-derived growth factor receptor.
Biochim Biophys Acta. 2011 Jan 20.
10) Piscitelli P., Marcucci G., Parri S., Cavalli L., Colli E., Pazzagli L., Batacchi P., Brocca T., Giovannini V., Brandi M.L. Compliance to antifracture treatments in Tuscany: a regional survey based on institutional pharmaceutical dataset.
Clin Cases Miner Bone Metab. 2011 Sep;8(3):62-5.
11) F. Falcini, L. Masi, L. Cavalli, A. Gozzini, F. Franceschelli, A. Falchetti, A. Amedei, G. Marcucci, C. Fossi, A. L. Tanini, M. L. Brandi (2011).
Mutations in GALNT3 GENE: Two adolescents with tumoral calcinosis-hyperphosphatemia.
Clinical And Experimental Rheumatology, vol. 29, p. 379-380, ISSN: 0392-856X
12) Falchetti A., Cavalli L., Cavalli T., Giusti F., Marcucci G., Marini F., Brandi M.L.
Molecular diagnosis of parathyroid carcinoma: a reality in the near future.
Expert Opin Med Diagn. 2012 Jan;6(1):27-37.
13) Romagnoli C., Marcucci G., Favilli F., Zonefrati R., Mavilia C., Galli G., Tanini A., Iantomasi T., Brandi M.L., Vincenzini M.T.
Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells.
FEBS J. 2013 Feb;280(3):867-79.
14) Piscitelli P., Iolascon G., Argentiero A., Chitano G., Neglia C., Marcucci G., Pulimeno M., Benvenuto M., Mundi S., Marzo V., Donati D., Baggiani A., Migliore A., Granata M., Gimigliano F., Di Blasio R., Gimigliano A., Renzulli L., Brandi M.L., Distante A., Gimigliano R.
Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records.
Clin Interv Aging. 2012;7:575-83.
15) Longato L., Cavalli L., Marcucci G., Metozzi A., Giusti F., Brandi M.L., Piscitelli P.
Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: a clinical case report.
Clin Cases Miner Bone Metab. 2013 May;10(2):139-41.
16) Marcucci G., Masi L., Carossino A.M., Franchi A., Capanna R., Sinigaglia L., Brandi M.L.
Cystic Bone Angiomatosis: A Case Report Treated with Aminobisphosphonates and Review of the Literature.
Calcif Tissue Int. 2013 Jul 9.
17) Marcucci G., Masi L., Cavalli L., Fossi C., Franceschelli F., Brandi M.L.
Is calcium signaling relevant for long bone growth?
Bone. 2013 Jul 25;57(1):105-110.
18) Masi L., Ottanelli S., Berni R., Cacudi E., Giusti F., Marcucci G., Cavalli L., Fossi C., Marini F., Ciuffi S., Tanini A., Brandi M.L. (2014). CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapy.
Clin Cases Miner Bone Metab., p. 36-43, ISSN: 1724-8914
19) Marcucci G, Zimran A, Bembi B, Kanis J, Reginster JY, Rizzoli R, Cooper C, Brandi ML.
Gaucher disease and bone manifestations.
Calcif Tissue Int. 2014 Dec;95(6):477-94.
20) Marcucci G, Cianferotti L, Beck-Peccoz P, Capezzone M, Cetani F, Colao A, Davì MV, Degli Uberti E, Del Prato S, Elisei R, Faggiano A, Ferone D, Foresta C, Fugazzola L, Ghigo E, Giacchetti G, Giorgino F, Lenzi A, Malandrino P, Mannelli M, Marcocci C, Masi L, Pacini F, Opocher G, Radicioni A, Tonacchera M, Vigneri R, Zatelli MC, Brandi ML.
Rare diseases in clinical endocrinology: a taxonomic classification system.
J Endocrinol Invest. 2014 Nov 7.
21) Fontani F, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling.
Calcif Tissue Int. 2015 Apr;96(4):335-46. doi: 10.1007/s00223-015-9961-0. Epub 2015 Feb 10.
22) Masi L, Beltrami G, Ottanelli S, Franceschelli F, Gozzini A, Zonefrati R, Galli G, Ciuffi S, Mavilia C, Giusti F, Marcucci G, Cioppi F, Colli E, Fossi C, Franchi A, Casentini C, Capanna R, Brandi ML.Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization.
Calcif Tissue Int. 2015 May;96(5):438-52. doi: 10.1007/s00223-015-9974-8. Epub 2015 Apr 23.
23) Parri S, Cianferotti L, Marcucci G, Gronchi G, Rizzuti C, Colli E, Manetti B, Naldoni W, Brandi ML. The T.A.R.Ge.T. project: a regional program to reduce hip fracture in elderly patients. Main results of retrospective phase.
Clin Cases Miner Bone Metab. 2015 Jan-Apr;12(1):34-42. doi: 10.11138/ccmbm/2015.12.1.034.
24) Marcucci G, Brandi ML. Rare causes of osteoporosis.
Clin Cases Miner Bone Metab. 2015 May-Aug;12(2):151-6. doi: 10.11138/ccmbm/2015.12.2.151. Epub 2015 Oct 26. Review.
25) Marcucci G, Della Pepa G, Brandi ML. Natpara for the treatment of hypoparathyroidism.
Expert Opin Biol Ther. 2016 Nov;16(11):1417-1424.
26) Marcucci G, Della Pepa G, Brandi ML.Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism. Expert Opin Drug Saf. 2017 May;16(5):617-625. doi: 10.1080/14740338.2017.1311322. Epub 2017 Apr 3. Review.
27) Domazetovic V, Fontani F, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Estrogen inhibits starvation-induced apoptosis in osteocytes by a redox-independent process involving association of JNK and glutathione S-transferase P1-1.
FEBS Open Bio. 2017 Apr 5;7(5):705-718. doi: 10.1002/2211-5463.12216.
28) Domazetovic V, Fontani F, Tanini D, D'Esopo V, Viglianisi C, Marcucci G, Panzella L, Napolitano A, Brandi ML, Capperucci A, Menichetti S, Vincenzini MT, Iantomasi T. Protective role of benzoselenophene derivatives of resveratrol on the induced oxidative stress in intestinal myofibroblasts and osteocytes. Chem Biol Interact. 2017 Jul 20. pii: S0009-2797(17)30202-8.
29) Tarantino U, Iolascon G, Cianferotti L, Masi L, Marcucci G, Giusti F, Marini F, Parri S, Feola M, Rao C, Piccirilli E, Zanetti EB, Cittadini N, Alvaro R, Moretti A, Calafiore D, Toro G, Gimigliano F, Resmini G, Brandi ML. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology.J Orthop Traumatol. 2017 Nov;18(Suppl 1):3-36. doi: 10.1007/s10195-017-0474-7.
30) Domazetovic V, Marcucci G, Iantomasi T, Brandi ML, Vincenzini MT. Oxidative stress in bone remodeling: role of antioxidants.Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):209-216.
31) HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy.
Marcucci G, Cianferotti L, Parri S, Altieri P, Arvat E, Benvenga S, Betterle C, Bondanelli M, Boscaro M, Camozzi V, Centaro GM, Cetani F, Chiodini I, Ciampolillo A, Colao A, Corbetta S, De Feo ML, Uberti ED, Faggiano A, Fornari R, Gaspari AL, Giorgino F, Giuliani V, Iacobone M, Innaro N, Lamacchia O, Lenzi A, Mantovani G, Marcocci C, Masi L, Migliaccio S, Palmieri S, Pasquali R, Perigli G, Piccini V, Romagnoli E, Ruggeri RM, Rulli F, Samà MT, Tomaino G, Trimarchi F, Zatelli MC, Brandi ML.
Calcif Tissue Int. 2018 Aug;103(2):151-163. doi: 10.1007/s00223-018-0411-7. Epub 2018 Mar 6.
32) Prevalence of Chronic Hypoparathyroidism in a Mediterranean Region as Estimated by the Analysis of Anonymous Healthcare Database.
Cianferotti L, Parri S, Gronchi G, Marcucci G, Cipriani C, Pepe J, Raglianti M, Minisola S, Brandi ML.
Calcif Tissue Int. 2018 Aug;103(2):144-150. doi: 10.1007/s00223-018-0405-5. Epub 2018 Mar 8.
33) Phosphate wasting disorders in adults.
Marcucci G, Masi L, Ferrarì S, Haffner D, Javaid MK, Kamenický P, Reginster JY, Rizzoli R, Brandi ML.
Osteoporos Int. 2018 Jul 16. doi: 10.1007/s00198-018-4618-2. [Epub ahead of print] Review.
34) Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters.
Vannucci L, Fossi C, Quattrini S, Guasti L, Pampaloni B, Gronchi G, Giusti F, Romagnoli C, Cianferotti L, Marcucci G, Brandi ML.
Nutrients. 2018 Dec 5;10(12). pii: E1930. doi: 10.3390/nu10121930. Review
35) A New Era for Chronic Management of Hypoparathyroidism: Parathyroid Hormone Peptides.
Marcucci G, Brandi ML.
Front Horm Res. 2019;51:165-171. doi: 10.1159/000491047. Epub 2018 Nov 19.
36) Conventional Treatment of Hypoparathyroidism.
Front Horm Res. 2019;51:160-164. doi: 10.1159/000491046. Epub 2018 Nov 19.
37) Causes and pathophysiology of hypoparathyroidism.
Cianferotti L, Marcucci G, Brandi ML.
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):909-925. doi: 10.1016/j.beem.2018.07.001. Epub 2018 Jul 29. Review.
38) Clinical presentation and management of hypoparathyroidism.
Marcucci G, Cianferotti L, Brandi ML.
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):927-939. doi: 10.1016/j.beem.2018.09.007. Epub 2018 Sep 28. Review.
39) Blueberry juice protects osteocytes and bone precursor cells against oxidative stress partly through SIRT1.
Domazetovic V, Marcucci G, Pierucci F, Bruno G, Di Cesare Mannelli L, Ghelardini C, Brandi ML, Iantomasi T, Meacci E, Vincenzini MT.
FEBS Open Bio. 2019 Jun;9(6):1082-1096. doi: 10.1002/2211-5463.12634. Epub 2019 Apr 20.
40) Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors.
Marcucci G, Beltrami G, Tamburini A, Body JJ, Confavreux CB, Hadji P, Holzer G, Kendler D, Napoli N, Pierroz DD, Rizzoli R, Brandi ML.
Ann Oncol. 2019 Jun 1;30(6):908-920. doi: 10.1093/annonc/mdz120.
41)Blueberry Juice Antioxidants Protect Osteogenic Activity against Oxidative Stress and Improve Long-Term Activation of the Mineralization Process in Human Osteoblast-Like SaOS-2 Cells: Involvement of SIRT1.
Domazetovic V, Marcucci G, Falsetti I, Bilia AR, Vincenzini MT, Brandi ML, Iantomasi T.
Antioxidants (Basel). 2020 Feb 1;9(2). pii: E125. doi: 10.3390/antiox9020125.
42) Congenital Conditions of Hypophosphatemia Expressed in Adults.
Calcif Tissue Int. 2021 Jan;108(1):91-103. doi: 10.1007/s00223-020-00695-2. Epub 2020 May 14.
43) Chronic hypoparathyroidism and treatment with teriparatide.
Marcucci G, Masi L, Cianferotti L, Giusti F, Fossi C, Parri S, Gronchi G, Brandi ML.
Endocrine. 2021 Apr;72(1):249-259. doi: 10.1007/s12020-020-02577-x. Epub 2021 Feb 4.
44) In Vitro Non-Genomic Effects of Calcifediol on Human Preosteoblastic Cells.
Donati S, Palmini G, Romagnoli C, Aurilia C, Miglietta F, Falsetti I, Marini F, Zonefrati R, Galli G, Marcucci G, Iantomasi T, Brandi ML.
Nutrients. 2021 Nov 25;13(12):4227. doi: 10.3390/nu13124227.
45) Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study.
Marcucci G, Altieri P, Benvenga S, Bondanelli M, Camozzi V, Cetani F, Cianferotti L, Duradoni M, Fossi C, Degli Uberti E, Famà F, Mantovani G, Marcocci C, Masi L, Pagotto U, Palermo A, Parri S, Ruggeri RM, Zatelli MC, Brandi ML; “Hypoparathyroidism Working Group” affiliated to the Italian Society of Endocrinology (S.I.E.).
Orphanet J Rare Dis. 2021 Oct 9;16(1):421. doi: 10.1186/s13023-021-02053-3.
46) Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia?
Masi L, Marini F, Franceschelli F, Leoncini G, Cianferotti L, Cioppi F, Giusti F, Marcucci G, Gronchi G, Brandi ML.
Osteoporos Int. 2021 Dec;32(12):2461-2472. doi: 10.1007/s00198-021-05893-8. Epub 2021 Jun 7.
47) Skeletal and extraskeletal disorders of biomineralization.
Collins MT, Marcucci G, Anders HJ, Beltrami G, Cauley JA, Ebeling PR, Kumar R, Linglart A, Sangiorgi L, Towler DA, Weston R, Whyte MP, Brandi ML, Clarke B, Thakker RV.
Nat Rev Endocrinol. 2022 Aug;18(8):473-489. doi: 10.1038/s41574-022-00682-7. Epub 2022 May 16.
48) Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment.
Marcucci G, Beccuti G, Carosi G, Cetani F, Cianferotti L, Colao AM, Di Somma C, Duradoni M, Elefante A, Ghizzoni L, Giusti M, Lania AG, Lavezzi E, Madeo B, Mantovani G, Marcocci C, Masi L, Parri S, Pigliaru F, Santonati A, Spada A, Vera L, Brandi ML.
J Endocrinol Invest. 2022 Apr 23. doi: 10.1007/s40618-022-01800-y. Online ahead of print.
49) ALPL Genotypes in Patients With Atypical Femur Fractures or Other Biochemical and Clinical Signs of Hypophosphatasia.
Marini F, Masi L, Giusti F, Cianferotti L, Cioppi F, Marcucci G, Ciuffi S, Biver E, Toro G, Iolascon G, Iantomasi T, Brandi ML.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2087-e2094. doi: 10.1210/clinem/dgab914.
50) Effect of Oxidative Stress-Induced Apoptosis on Active FGF23 Levels in MLO-Y4 Cells: The Protective Role of 17-β-Estradiol. Domazetovic V, Falsetti I, Ciuffi S, Iantomasi T, Marcucci G, Vincenzini MT, Brandi ML. Int J Mol Sci. 2022 Feb 14;23(4):2103. doi: 10.3390/ijms23042103.
51) ALPL Genotypes in Patients With Atypical Femur Fractures or Other Biochemical and Clinical Signs of Hypophosphatasia.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2087-e2094. doi: 10.1210/clinem/dgab914. PMID: 34935951
52) Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment. Marcucci G, Beccuti G, Carosi G, Cetani F, Cianferotti L, Colao AM, Di Somma C, Duradoni M, Elefante A, Ghizzoni L, Giusti M, Lania AG, Lavezzi E, Madeo B, Mantovani G, Marcocci C, Masi L, Parri S, Pigliaru F, Santonati A, Spada A, Vera L, Brandi ML. J
Endocrinol Invest. 2022 Sep;45(9):1653-1662. doi: 10.1007/s40618-022-01800-y. Epub 2022 Apr 23.
53) Skeletal and extraskeletal disorders of biomineralization. Collins MT, Marcucci G, Anders HJ, Beltrami G, Cauley JA, Ebeling PR, Kumar R, Linglart A, Sangiorgi L, Towler DA, Weston R, Whyte MP, Brandi ML, Clarke B, Thakker RV. Nat Rev Endocrinol. 2022 Aug;18(8):473-489. doi: 10.1038/s41574-022-00682-7. Epub 2022 May 16.
54) Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches. Marcucci G, Domazetovic V, Nediani C, Ruzzolini J, Favre C, Brandi ML. Antioxidants (Basel). 2023 Feb 3;12(2):373. doi: 10.3390/antiox12020373.
Date: 16/October/2023